z-logo
open-access-imgOpen Access
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors
Author(s) -
Patrizia Vici,
Laura Pizzuti,
Eriseld Krasniqi,
Andrea Botticelli,
Gennaro Ciliberto,
Maddalena Barba
Publication year - 2020
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt-2020-0142
Subject(s) - breast cancer , triple negative breast cancer , medicine , cancer , clinical oncology , covid-19 , oncology , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here